Suggested Topics within your search.
Suggested Topics within your search.
- Pharmaceutical Preparations 7
- Pharmacology 4
- administration & dosage 4
- Drugs 3
- Drug Dosage Calculations 2
- Drug Therapy 2
- Examinations 2
- Licenses 2
- Pharmaceutical arithmetic 2
- Physicians 2
- Biological Factors 1
- Dosage 1
- Drug development 1
- Geneesmiddelen 1
- Law and legislation 1
- Mathematics 1
- Matière médicale 1
- Médicaments 1
- Nursing 1
- Nursing Care 1
- Pharmaceutical chemistry 1
- Pharmaceutical industry 1
- Produits biologiques 1
- Programmed instruction 1
- Testing 1
- methods 1
-
2401
Two chromatographic methods for analyzing paracetamol in spiked human plasma with its toxic metabolite, N-acetyl parabenzoquinone imine and its antidote, N-acetyl-l-cysteine
Published 2025-02-01“…Abstract Acetaminophen, also known as paracetamol (APAP), is a highly utilized pharmaceutical agent on a global scale, particularly in the field of pediatrics. …”
Get full text
Article -
2402
Biomarker Profiling for Pyridoxine Dependent Epilepsy in Dried Blood Spots by HILIC-ESI-MS
Published 2018-01-01Get full text
Article -
2403
Approaches and applications in transdermal and transpulmonary gene drug delivery
Published 2025-01-01Get full text
Article -
2404
-
2405
-
2406
Usability Evaluation of Foods with Function Claims Labelling as Health Information in Japan: A User-Testing Study
Published 2025-02-01“…Michiko Yamamoto,1,* Ken Yamamoto,2,* Hiromi Takano-Ohmuro,3 Rain Yamamoto,4 Junji Saruwatari1 1Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto-city, Kumamoto, Japan; 2Showa Pharmaceutical University, Machida-city, Tokyo, Japan; 3Faculty of Pharmacy, Musashino University, Nishitokyo-city, Tokyo, Japan; 4Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan*These authors contributed equally to this workCorrespondence: Michiko Yamamoto, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Chuo-ku, Kumamoto-city, Kumamoto, Japan, Email m-yamamoto@kumamoto-u.ac.jpPurpose: The saturation of health foods in the market is coupled with inadequate information on their safe usage. …”
Get full text
Article -
2407
The Burden of Illness in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease in Canada
Published 2012-01-01Get full text
Article -
2408
A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection
Published 2003-01-01Get full text
Article -
2409
Spectrophotometric Determination of Ezetimibe
Published 2010-01-01“…Two simple, sensitive, selective and accurate spectro-photometric methods (Method A and Method B) for the determination of eztimibe in bulk drug and pharmaceutical formulations (tablets) have been described. …”
Get full text
Article -
2410
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
Published 2019-01-01“…The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. …”
Get full text
Article -
2411
Suspected Intramural Spread of Dye during Transaortic Celiac Plexus Rhizolysis in Patient of Intra-abdominal Malignancy
Published 2024-12-01“…A minimally invasive pain intervention, such as celiac plexus rhizolysis, may be needed to treat individuals whose pain is resistant to pharmaceutical therapy. Although celiac plexus rhizolysis is an effective and relatively safer technique, fatal complications such as aortic pseudoaneurysm or dissection are possible. …”
Get full text
Article -
2412
Development of Class IIa Bacteriocins as Therapeutic Agents
Published 2012-01-01“…The suitability of bacteriocins as pharmaceuticals is explored through determinations of cytotoxicity, effects on the natural microbiota, and in vivo efficacy in mouse models. …”
Get full text
Article -
2413
A shortage of funding or not enough healthcare projects?
Published 2024-09-01“…1727462674"> The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research projects into commercial development, mainly in Europe. …”
Get full text
Article -
2414
New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14
Published 2025-01-01Get full text
Article -
2415
Resistant Starch Contents of Native and Heat-Moisture Treated Jackfruit Seed Starch
Published 2015-01-01“…Native jackfruit seed starch (JFS) contains 30% w/w type II resistant starch (RS2) and can potentially be developed as a new commercial source of RS for food and pharmaceutical application. Heat-moisture treatment (HMT) was explored as a mean to increase RS content of native JFS. …”
Get full text
Article -
2416
-
2417
Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography
Published 2024-09-01Get full text
Article -
2418
-
2419
-
2420